BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34928333)

  • 1. Highly Sensitive Detection Method of DICER1 Tumor Hotspot Mutations by Drop-off Droplet Digital PCR.
    Vibert R; Gauthier-Villars M; Carrière C; Dubois d'Enghien C; Cyrta J; Vincent-Salomon A; Stoppa-Lyonnet D; Bièche I; Jeannot E; Golmard L
    Clin Chem; 2022 Feb; 68(2):322-331. PubMed ID: 34928333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predominant
    Lee YA; Im SW; Jung KC; Chung EJ; Shin CH; Kim JI; Park YJ
    Thyroid; 2020 Aug; 30(8):1120-1131. PubMed ID: 32228164
    [No Abstract]   [Full Text] [Related]  

  • 3. The prevalence of germline DICER1 pathogenic variation in cancer populations.
    Kim J; Schultz KAP; Hill DA; Stewart DR
    Mol Genet Genomic Med; 2019 Mar; 7(3):e555. PubMed ID: 30672147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial multinodular goiter and Sertoli-Leydig cell tumors associated with a large intragenic in-frame
    Apellaniz-Ruiz M; de Kock L; Sabbaghian N; Guaraldi F; Ghizzoni L; Beccuti G; Foulkes WD
    Eur J Endocrinol; 2018 Feb; 178(2):K11-K19. PubMed ID: 29187512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DICER1 hotspot mutations in non-epithelial gonadal tumours.
    Witkowski L; Mattina J; Schönberger S; Murray MJ; Choong CS; Huntsman DG; Reis-Filho JS; McCluggage WG; Nicholson JC; Coleman N; Calaminus G; Schneider DT; Arseneau J; Stewart CJ; Foulkes WD
    Br J Cancer; 2013 Nov; 109(10):2744-50. PubMed ID: 24136150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The co-occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1 syndrome.
    Durieux E; Descotes F; Mauduit C; Decaussin M; Guyetant S; Devouassoux-Shisheboran M
    Virchows Arch; 2016 May; 468(5):631-6. PubMed ID: 26983701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Spectrum of DICER1 Mutations in Adult-onset Thyroid Nodules with Indeterminate Cytology.
    Chong AS; Nikiforov YE; Condello V; Wald AI; Nikiforova MN; Foulkes WD; Rivera B
    J Clin Endocrinol Metab; 2021 Mar; 106(4):968-977. PubMed ID: 33460435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A complex DICER1 syndrome phenotype associated with a germline pathogenic variant affecting the RNase IIIa domain of DICER1.
    Pontén E; Frisk S; Taylan F; Vaz R; Wessman S; de Kock L; Pal N; Foulkes WD; Lagerstedt-Robinson K; Nordgren A
    J Med Genet; 2022 Feb; 59(2):141-146. PubMed ID: 33208384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal Type Morphologies Suggest the Presence of DICER1 Hotspot Mutations in Non-small Cell Lung Cancer.
    Chong AL; Thorner P; Ellis M; Swensen J; Benlimame N; Fiset PO; Gatalica Z; Evans MG; Foulkes WD
    Am J Surg Pathol; 2024 Feb; 48(2):221-229. PubMed ID: 38050371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects.
    Kato N; Kusumi T; Kamataki A; Tsunoda R; Fukase M; Kurose A
    Hum Pathol; 2017 Jan; 59():41-47. PubMed ID: 27664536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesis.
    Chen J; Wang Y; McMonechy MK; Anglesio MS; Yang W; Senz J; Maines-Bandiera S; Rosner J; Trigo-Gonzalez G; Grace Cheng SW; Kim J; Matzuk MM; Morin GB; Huntsman DG
    J Pathol; 2015 Oct; 237(2):215-25. PubMed ID: 26033159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ovarian Sertoli-Leydig cell tumors: DICER1 hotspot mutations and associated clinicopathological features].
    Xiao YX; Zhu XL; Bi R; Tu XY; Cheng YF; Chang B; Yu L; Huang D; Lu YM; Shan L; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):441-447. PubMed ID: 32392927
    [No Abstract]   [Full Text] [Related]  

  • 13.
    Hurdogan O; Yilmaz I; Bay SB; Vural S; Tugcu D; Kebudi R; Gun F; Ozkan B; Bilgic B; Firat P; Yilmazbayhan D; Ozluk Y
    Pediatr Dev Pathol; 2020; 23(3):204-209. PubMed ID: 31603374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Molecular Characteristics May Alter Treatment Strategies of Thyroid Malignancies in DICER1 Syndrome.
    van der Tuin K; de Kock L; Kamping EJ; Hannema SE; Pouwels MM; Niedziela M; van Wezel T; Hes FJ; Jongmans MC; Foulkes WD; Morreau H
    J Clin Endocrinol Metab; 2019 Feb; 104(2):277-284. PubMed ID: 30260442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleuropulmonary Blastoma with Hotspot Mutations in RNase IIIb Domain of DICER 1: Clinicopathologic Study of 10 Cases in a Single-Institute Experience.
    Lee M; Kim TI; Jang SJ; Cho KJ; Lee SM; Kim HR; Song JS
    Pathobiology; 2021; 88(3):251-260. PubMed ID: 33567437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-sensitivity sequencing reveals multi-organ somatic mosaicism causing DICER1 syndrome.
    de Kock L; Wang YC; Revil T; Badescu D; Rivera B; Sabbaghian N; Wu M; Weber E; Sandoval C; Hopman SM; Merks JH; van Hagen JM; Bouts AH; Plager DA; Ramasubramanian A; Forsmark L; Doyle KL; Toler T; Callahan J; Engelenberg C; Bouron-Dal Soglio D; Priest JR; Ragoussis J; Foulkes WD
    J Med Genet; 2016 Jan; 53(1):43-52. PubMed ID: 26475046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage.
    Anglesio MS; Wang Y; Yang W; Senz J; Wan A; Heravi-Moussavi A; Salamanca C; Maines-Bandiera S; Huntsman DG; Morin GB
    J Pathol; 2013 Feb; 229(3):400-9. PubMed ID: 23132766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors.
    Wang Y; Chen J; Yang W; Mo F; Senz J; Yap D; Anglesio MS; Gilks B; Morin GB; Huntsman DG
    Neoplasia; 2015 Aug; 17(8):650-60. PubMed ID: 26408257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype.
    Mirshahi UL; Kim J; Best AF; Chen ZE; Hu Y; Haley JS; Golden A; Stahl R; Manickam K; Carr AG; Harney LA; Field A; Hatton J; Schultz KAP; Bauer AJ; Hill DA; Rosenberg PS; Murray MF; Carey DJ; Stewart DR
    JAMA Netw Open; 2021 Feb; 4(2):e210112. PubMed ID: 33630087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
    Heravi-Moussavi A; Anglesio MS; Cheng SW; Senz J; Yang W; Prentice L; Fejes AP; Chow C; Tone A; Kalloger SE; Hamel N; Roth A; Ha G; Wan AN; Maines-Bandiera S; Salamanca C; Pasini B; Clarke BA; Lee AF; Lee CH; Zhao C; Young RH; Aparicio SA; Sorensen PH; Woo MM; Boyd N; Jones SJ; Hirst M; Marra MA; Gilks B; Shah SP; Foulkes WD; Morin GB; Huntsman DG
    N Engl J Med; 2012 Jan; 366(3):234-42. PubMed ID: 22187960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.